share_log

康健國際醫療:股東週年大會投票結果

TOWN HEALTH: POLL RESULTS OF THE ANNUAL GENERAL MEETING

HKEX ·  Jun 12, 2024 19:03

Summary by Moomoo AI

康健國際醫療集團有限公司於2024年6月12日召開股東週年大會,除第9至11項決議案外,包括財務報表通過、末期股息宣派、董事選舉及股份發行等決議案均獲得通過。該公司於2024年5月17日及5月28日分別發布通函及補充通函,提出上述議案。在出席會議的6,773,522,452股已發行股份中,大部分決議案獲得超過99%的贊成票,但黃自傑醫生、姚遠女士及江鵬先生的董事委任未獲足夠票數通過。股東週年大會的投票由卓佳登捷時有限公司監票。
康健國際醫療集團有限公司於2024年6月12日召開股東週年大會,除第9至11項決議案外,包括財務報表通過、末期股息宣派、董事選舉及股份發行等決議案均獲得通過。該公司於2024年5月17日及5月28日分別發布通函及補充通函,提出上述議案。在出席會議的6,773,522,452股已發行股份中,大部分決議案獲得超過99%的贊成票,但黃自傑醫生、姚遠女士及江鵬先生的董事委任未獲足夠票數通過。股東週年大會的投票由卓佳登捷時有限公司監票。
Town Health International Medical Group Limited held its annual shareholders' meeting on June 12, 2024. Except for resolutions 9 to 11 that were not passed, resolutions including the approval of financial statements, declaration of final dividends, election of directors and issuance of shares were all passed. The company issued circulars and supplemental circulars on May 17 and May 28, 2024, proposing the above resolutions. Among the 6,773,522,452 issued shares present at the meeting, most resolutions received over 99% of affirmative votes, but the appointment of Dr. Huang Zijie, Ms. Yao Yuan and Mr. Jiang Peng as directors did not receive sufficient votes. The shareholder annual meeting was supervised by Deloitte Touche Tohmatsu Limited.
Town Health International Medical Group Limited held its annual shareholders' meeting on June 12, 2024. Except for resolutions 9 to 11 that were not passed, resolutions including the approval of financial statements, declaration of final dividends, election of directors and issuance of shares were all passed. The company issued circulars and supplemental circulars on May 17 and May 28, 2024, proposing the above resolutions. Among the 6,773,522,452 issued shares present at the meeting, most resolutions received over 99% of affirmative votes, but the appointment of Dr. Huang Zijie, Ms. Yao Yuan and Mr. Jiang Peng as directors did not receive sufficient votes. The shareholder annual meeting was supervised by Deloitte Touche Tohmatsu Limited.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more